CCL2 and COVID-19: In an early study, it was observed that COVID-19 patients who develop the severe form and are hospitalized and exhibit several inflammatory cytokines including IL-2, IL-7, IL-10, G-CSF, IP-10, MCP1, MIP1α, and TNF (Huang et al., 2020).